Parameter
| Biomarker | IL-6 | Full name | Interleukin-6 | Molecular Type | Cytokine |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prediction, Monitoring |
| Disease | Epilepsy | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Serum/Cerebrospinal Fluid (ELISA, qPCR) | ||
| Pathobiological Mechanisms | Activates the JAK-STAT pathway, promotes neuroinflammation, and reduces ASM sensitivity. | ||||
| Clinical Availability Status | Under clinical validation | ||||
| Notes and Dynamics | CSF IL-6 levels in drug-refractory epilepsy patients are 2.3 times higher than those in sensitive patients; IL-6 receptor antagonists can improve seizures in some patients. | ||||